Latest

AspirePeak Properties Ltd. Formally Launches Condominium Management Division, Now Accepting Condo Board Proposals in Calgary, AB

AspirePeak Properties Ltd. Formally Launches Condominium Management Division, Now Accepting Condo Board Proposals in Calgary, AB

AspirePeak Properties Ltd., a licensed Calgary property management brokerage with RECA, has formally launched its Condominium Management Division and is now accepting condo board proposals. Backed by over 20 years of combined experience and led by Condo Broker Chris Hochheimer, the team offers hands-on, licensed condominium management for communities
MSU Exponent Contributor
Cetera Welcomes Advisor Douglas Morey and His MTI Financial Advisors Team Overseeing Approximately $350 Million in AUA

Cetera Welcomes Advisor Douglas Morey and His MTI Financial Advisors Team Overseeing Approximately $350 Million in AUA

Minnesota-based firm joins Cetera from Osaic, seeking greater support for its personalized approach to relationship-driven wealth management SAN DIEGO, June 16, 2026 /PRNewswire/ -- Cetera welcomes financial advisor Douglas Morey, founder and President of MTI Financial Advisors, and his team including advisors Christopher Bayliss and Thomas Scheck who join
Cetera Financial Group
Coreshell Technologies Enters Defense Market with a Scalable, Fully Domestic Battery Platform for Defense Applications

Coreshell Technologies Enters Defense Market with a Scalable, Fully Domestic Battery Platform for Defense Applications

ADS invests in Coreshell to strengthen the domestic supply chain and bring American-made batteries to the DOW DETROIT, June 16, 2026 /PRNewswire/ -- Coreshell Technologies today announced its expansion into the defense market, offering the only high-performance batteries that are simultaneously scalable, mission-ready, and entirely free of Foreign
Coreshell Technologies
Nervonik Announces Completion of Groundbreaking First-in-Human Feasibility Study Demonstrating Nerve Sensing during Peripheral Nerve Stimulation in Multiple Anatomical Targets

Nervonik Announces Completion of Groundbreaking First-in-Human Feasibility Study Demonstrating Nerve Sensing during Peripheral Nerve Stimulation in Multiple Anatomical Targets

LOS ANGELES, June 16, 2026 /PRNewswire/ -- Nervonik, a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today announced the completion of a first-in-human feasibility study demonstrating the ability to record key nerve-related biosignals from 16 peripheral nerves in 8 chronic pain patients
Nervonik Inc.